Tokyo Tape
Sign in

StemRIM

4599.TTSE GROWTHPharmaceutical
Key numbers · FY ended 2023-07
Revenue¥2.4bn+10128.1% YoYOperating income−¥2.0bn—Total assets¥7.5bn-17.2% YoYEPS (basic)¥-31.16+5.5% YoY

Full financial history and reports →

Stock price4599 · View chart ↗

Open the price chart on TradingView.

Latest filings
Wed, Sep 9 · JST1 filing
16:55MATERIALStemRIM · Change of representative director
Thu, Aug 27 · JST1 filing
16:245% STAKEStemRIM · Tomita Kensuke + 1 joint holder · 6.72% → 5.52%−1.20pp
Thu, Aug 20 · JST1 filing
16:035% STAKEStemRIM · Tomita Kensuke + 1 joint holder · 7.92% → 6.72%−1.20pp
Tue, Jul 21 · JST1 filing
16:345% STAKEStemRIM · Tomita Kensuke + 1 joint holder · 8.92% → 7.92%−1.00pp
Tue, Jul 7 · JST1 filing
16:045% STAKEStemRIM · Tomita Kensuke + 1 joint holder · 9.96% → 8.92%−1.04pp

All filings →

Major holders (5%+) · 2
HolderStakeChangeFiled
Gomi Daisuke7.32%—2024-06-14
Tomita Kensuke5.52%-1.20pp2026-08-27

Each holder's own ratio from its most recent large-shareholding report.